| Today, Tue, Nov 24, 2009 | | • | [video] Topping the Tape
at CNBC (Tue 5:20pm)
| | • | Signals Favor a Santa Claus Rally
at Minyanville.com (Tue 2:20pm)
| | Mon, Nov 23, 2009 | | • | Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards
PR Newswire (Mon 3:05pm)
| | • | 5 Top Stocks at Half Price
at Motley Fool (Mon 12:25pm)
| | Sun, Nov 22, 2009 | | • | Proxy-Voting Advocates Pool Resources on the Web
at The Wall Street Journal Online (Sun, Nov 22)
| | • | 7 Stocks That Are Swimming in Cash
at Motley Fool (Sun, Nov 22)
| | Sat, Nov 21, 2009 | | • | Healthcare bill gains ahead of U.S. Senate test
at Reuters (Sat, Nov 21)
| | • | Winners, losers in U.S. Senate health bill
at Reuters (Sat, Nov 21)
| | Fri, Nov 20, 2009 | | • | Uncertainty Breeds Opportunity in Specialty Pharma Stock Pick From Piper Jaffray Senior Research Analyst
Wall Street Transcript (Fri, Nov 20)
| | Thu, Nov 19, 2009 | | • | UPDATE - ImmunoGen licenses anti-cancer technology to Amgen
at Reuters (Thu, Nov 19)
| | • | ImmunoGen licenses technology to Amgen for $1M
AP (Thu, Nov 19)
| | • | This Stock Is a Train Wreck
at Motley Fool (Thu, Nov 19)
| | • | UPDATE - EU panel blocks Merck KGaA's Erbitux in lung cancer
at Reuters (Thu, Nov 19)
| | • | Moody's gives negative view on pharma credit
AP (Thu, Nov 19)
| | • | UPDATE - Healthcare stocks not unduly hurt by Senate plan
at Reuters (Thu, Nov 19)
| | • | Follow the Smart Money
at Motley Fool (Thu, Nov 19)
| | Wed, Nov 18, 2009 | | • | Winners, losers in U.S. Senate health bill
at Reuters (Wed, Nov 18)
| | • | Trading Biotech Breakthroughs
at CNBC (Wed, Nov 18)
| | • | The Type of Stock You Should Never, Ever Buy
at Motley Fool (Wed, Nov 18)
| | • | Portfolio Managers' Stock Picks: Large and Small Caps
at CNBC (Wed, Nov 18)
|
Add AMGN News to My Yahoo!:
 
| |
|
0.16% Nasdaq 
0.55 (0.98%) 
Headlines
